| Pathway ID | hsa04080 |
| Pathway Term | Neuroactive ligand-receptor interaction |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ADCYAP1R1 | adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
117 | P41586 | chr7: 31,052,461-31,111,479 |
ADORA1 | adenosine A1 receptor |
134 | P30542 | chr1: 203,090,654-203,167,405 |
ADORA2B | adenosine A2b receptor |
136 | P29275 | chr17: 15,944,917-15,975,746 |
ADRA1A | adrenoceptor alpha 1A |
148 | P35348 | chr8: 26,748,150-26,867,273 |
ADRA1B | adrenoceptor alpha 1B |
147 | P35368 | chr5: 159,865,080-159,972,544 |
ADRA1D | adrenoceptor alpha 1D |
146 | P25100 | chr20: 4,220,631-4,249,074 |
ADRA2B | adrenoceptor alpha 2B |
151 | P18089 | chr2: 96,112,875-96,116,245 |
ADRB1 | adrenoceptor beta 1 |
153 | P08588 | chr10: 114,044,056-114,046,908 |
ADRB2 | adrenoceptor beta 2 |
154 | P07550 | chr5: 148,825,245-148,828,687 |
ADRB3 | adrenoceptor beta 3 |
155 | P13945 | chr8: 37,962,991-37,966,965 |
AGTR1 | angiotensin II receptor, type 1 |
185 | P30556 | chr3: 148,697,784-148,743,008 |
AGTR2 | angiotensin II receptor, type 2 |
186 | P50052 | chrX: 116,170,722-116,174,972 |
AVPR2 | arginine vasopressin receptor 2 |
554 | P30518 | chrX: 153,902,531-153,907,166 |
C5AR1 | complement component 5a receptor 1 |
728 | P21730 | chr19: 47,290,023-47,322,066 |
CCKBR | cholecystokinin B receptor |
887 | P32239 | chr11: 6,259,736-6,272,127 |
CGA | glycoprotein hormones, alpha polypeptide |
1081 | P01215 | chr6: 87,085,498-87,095,406 |
CHRM2 | cholinergic receptor, muscarinic 2 |
1129 | P08172 | chr7: 136,868,669-137,020,255 |
CHRM3 | cholinergic receptor, muscarinic 3 |
1131 | P20309 | chr1: 239,386,565-239,915,452 |
CHRNA5 | cholinergic receptor, nicotinic alpha 5 |
1138 | P30532 | chr15: 78,565,520-78,595,269 |
CHRNA7 | cholinergic receptor, nicotinic alpha 7 |
1139 | P36544 | chr15: 31,923,438-32,173,018 |
CHRNB1 | cholinergic receptor, nicotinic beta 1 |
1140 | P11230 | chr17: 7,445,061-7,457,707 |
CNR1 | cannabinoid receptor 1 (brain) |
1268 | P21554 | chr6: 88,139,864-88,166,359 |
DRD2 | dopamine receptor D2 |
1813 | P14416 | chr11: 113,409,615-113,475,691 |
EDNRA | endothelin receptor type A |
1909 | P25101 | chr4: 147,480,917-147,544,954 |
F2 | coagulation factor II (thrombin) |
2147 | P00734 | chr11: 46,719,180-46,739,506 |
F2R | coagulation factor II (thrombin) receptor |
2149 | P25116 | chr5: 76,716,043-76,735,781 |
F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
2150 | P55085 | chr5: 76,818,933-76,835,315 |
FPR1 | formyl peptide receptor 1 |
2357 | P21462 | chr19: 51,745,172-51,804,110 |
FPR2 | formyl peptide receptor 2 |
2358 | P25090 | chr19: 51,752,026-51,770,526 |
FSHB | follicle stimulating hormone, beta polypeptide |
2488 | P01225 | chr11: 30,231,016-30,235,261 |
FSHR | follicle stimulating hormone receptor |
2492 | P23945 | chr2: 48,962,157-49,154,537 |
GABBR1 | gamma-aminobutyric acid (GABA) B receptor, 1 |
2550 | Q9UBS5 | chr6: 29,555,629-29,633,976 |
GABBR2 | gamma-aminobutyric acid (GABA) B receptor, 2 |
9568 | O75899 | chr9: 98,288,082-98,709,197 |
GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
2558 | P31644 | chr15: 26,866,363-26,949,207 |
GH1 | growth hormone 1 |
2688 | P01241 | chr17: 63,917,200-63,918,838 |
GHR | growth hormone receptor |
2690 | P10912 | chr5: 42,423,777-42,721,878 |
GHSR | growth hormone secretagogue receptor |
2693 | Q92847 | chr3: 172,445,133-172,448,456 |
GLRB | glycine receptor beta |
2743 | P48167 | chr4: 157,076,057-157,172,090 |
GNRHR | gonadotropin releasing hormone receptor |
2798 | P30968 | chr4: 67,739,328-67,754,360 |
GRIA4 | glutamate receptor, ionotropic, AMPA 4 |
2893 | P48058 | chr11: 105,609,994-105,982,092 |
GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
2903 | Q12879 | chr16: 9,753,404-10,182,754 |
GRM3 | glutamate receptor, metabotropic 3 |
2913 | Q14832 | chr7: 86,643,914-86,864,884 |
GRM6 | glutamate receptor, metabotropic 6 |
2916 | O15303 | chr5: 178,978,327-178,996,206 |
GRM8 | glutamate receptor, metabotropic 8 |
2918 | O00222 | chr7: 126,438,598-127,253,294 |
HRH1 | histamine receptor H1 |
3269 | P35367 | chr3: 11,137,093-11,263,557 |
HRH3 | histamine receptor H3 |
11255 | Q9Y5N1 | chr20: 62,214,970-62,220,267 |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
3357 | P41595 | chr2: 231,108,230-231,125,118 |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
3358 | P28335 | chrX: 114,584,078-114,910,061 |
HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
3363 | P34969 | chr10: 90,740,823-90,857,698 |
KISS1R | KISS1 receptor |
84634 | Q969F8 | chr19: 917,287-921,015 |
LEP | leptin |
3952 | P41159 | chr7: 128,241,284-128,257,628 |
LEPR | leptin receptor |
3953 | P48357 | chr1: 65,420,652-65,641,559 |
LHB | luteinizing hormone beta polypeptide |
3972 | P01229 | chr19: 49,015,980-49,017,081 |
LHCGR | luteinizing hormone/choriogonadotropin receptor |
3973 | P22888 | chr2: 48,686,775-48,755,730 |
MC2R | melanocortin 2 receptor (adrenocorticotropic hormone) |
4158 | Q01718 | chr18: 13,882,044-13,915,707 |
MC4R | melanocortin 4 receptor |
4160 | P32245 | chr18: 60,371,110-60,372,775 |
MTNR1A | melatonin receptor 1A |
4543 | P48039 | chr4: 186,533,655-186,555,567 |
MTNR1B | melatonin receptor 1B |
4544 | P49286 | chr11: 92,969,720-92,985,066 |
NPBWR1 | neuropeptides B/W receptor 1 |
2831 | P48145 | chr8: 52,938,431-52,941,117 |
NPY1R | neuropeptide Y receptor Y1 |
4886 | P25929 | chr4: 163,323,961-163,344,832 |
NPY2R | neuropeptide Y receptor Y2 |
4887 | P49146 | chr4: 155,208,629-155,217,078 |
NPY5R | neuropeptide Y receptor Y5 |
4889 | Q15761 | chr4: 163,343,939-163,351,934 |
NR3C1 | nuclear receptor subfamily 3 group C member 1 |
2908 | P04150 | chr5: 143,277,931-143,435,512 |
OPRL1 | opiate receptor-like 1 |
4987 | P41146 | chr20: 64,080,173-64,100,643 |
OXTR | oxytocin receptor |
5021 | P30559 | chr3: 8,750,408-8,769,628 |
P2RX4 | purinergic receptor P2X, ligand gated ion channel, 4 |
5025 | Q99571 | chr12: 121,209,857-121,234,106 |
P2RY14 | purinergic receptor P2Y, G-protein coupled, 14 |
9934 | Q15391 | chr3: 151,212,117-151,278,467 |
P2RY8 | purinergic receptor P2Y, G-protein coupled, 8 |
286530 | Q86VZ1 | chrX: 1,462,572-1,537,107 |
PARD3 | par-3 family cell polarity regulator |
56288 | Q8TEW0 | chr10: 34,109,560-34,815,325 |
PLG | plasminogen |
5340 | P00747 | chr6: 160,702,238-160,753,315 |
PRL | prolactin |
5617 | P01236 | chr6: 22,287,244-22,297,501 |
PRLR | prolactin receptor |
5618 | P16471 | chr5: 35,048,756-35,230,589 |
PRSS1 | protease, serine 1 |
5644 | P07477 | chr7: 142,749,468-142,753,076 |
PRSS3 | protease, serine 3 |
5646 | P35030 | chr9: 33,750,466-33,799,231 |
PTAFR | platelet-activating factor receptor |
5724 | P25105 | chr1: 28,147,166-28,193,936 |
PTGDR | prostaglandin D2 receptor (DP) |
5729 | Q13258 | chr14: 52,267,713-52,276,724 |
PTGER2 | prostaglandin E receptor 2 |
5732 | P43116 | chr14: 52,314,305-52,328,606 |
PTGER3 | prostaglandin E receptor 3 |
5733 | P43115 | chr1: 70,852,353-71,047,808 |
PTGER4 | prostaglandin E receptor 4 |
5734 | P35408 | chr5: 40,679,498-40,693,735 |
PTGFR | prostaglandin F receptor (FP) |
5737 | P43088 | chr1: 78,303,884-78,539,749 |
PTH2R | parathyroid hormone 2 receptor |
5746 | P49190 | chr2: 208,359,714-208,854,503 |
S1PR1 | sphingosine-1-phosphate receptor 1 |
1901 | P21453 | chr1: 101,236,888-101,241,518 |
S1PR3 | sphingosine-1-phosphate receptor 3 |
1903 | Q99500 | chr9: 88,991,447-89,005,010 |
SSTR1 | somatostatin receptor 1 |
6751 | P30872 | chr14: 38,207,999-38,213,067 |
SSTR5 | somatostatin receptor 5 |
6755 | P35346 | chr16: 1,078,781-1,080,142 |
THRA | thyroid hormone receptor, alpha |
7067 | P10827 | chr17: 40,058,290-40,093,867 |
TRPV1 | transient receptor potential cation channel, subfamily V, member 1 |
7442 | Q8NER1 | chr17: 3,565,444-3,609,411 |
TSPO | translocator protein |
706 | P30536 | chr22: 43,151,514-43,163,242 |